Makeup
Abonnement-Boxen
Augenbrauenprodukte
Augengrundierungen
BB & CC Cremes
Bürsten & Werkzeuge
Concealer
Falsche Nägel
Foundations
Gesichts- & Körperglitter
Gesichtsgrundierungen
Gesichtspuder
Highlighter
Konturprodukte
Lidschatten
Lipglosse
Lipliner
Lippenstifte
Lippenvolumen-Produkte
Makeup-Fixiersprays
Makeup-Paletten
Nagellacke
Nagelpflegeprodukte
Wimpern-Grundierungen
Wimpernprodukte
Zufällige Produkte
Hautpflege
Anti-Aging-Cremes
Augenpflegeprodukte
Bade- & Duschprodukte
Fußpflegeprodukte
Gesichtsfeuchtigkeitscremes
Haarentfernungsprodukte
Handpflegeprodukte
Körperfeuchtigkeitscremes
Körperpeelings
Lippenpflegeprodu
Parfums
Peelings & Masken
Problemhautpflegeprodukte
Reinigungsmittel
Selbstbräunungsprodukte
Sonnenpflegeprodukte
Haarpflege
Beheizte Stylingwerkzeuge
Conditioner
Haarbürsten & Zubehör
Haarfarbeprodukte
Haarschutzprodukte
Haarstylingprodukte
hair_treatment_and_masks
Kopfhautpflege
Shampoos
Geschenk
Geschenksets
Phyto A+ Brightening Treatment, an oil-free, lightweight moisturizer with a gel-creme texture targets dullness, redness, and excess oil production even on sensitive skin. Specially formulated with 3% azelaic acid to target clogged pores, making it the perfect complement for oily and blemish-prone skin. Achieve bright, smooth, and clear skin with this gentle daily moisturizer with a soothing botanical blend of cucumber, thyme, and olive leaf extracts. Key Benefits: Brightens, while reducing post-blemish marks by 20% * Smooths, while improving rough skin texture by 19% * Clarifies, while reducing pore-clogging surface oil by 28% * Lightweight, gel-creme texture Oil- & Silicone-Free Non-comedogenic Suitable for sensitive skin Clinically effective and studied in all skin tones *Protocol: A 12-week, single-center, clinical study was conducted on 64 female and male subjects, ages 18 to 55, Fitzpatrick I-VI, with normal to oily skin types and mild to moderate skin discoloration and rough texture. Phyto A+ Brightening Treatment was applied to the face twice a day in conjunction with a sunscreen. Evaluations were conducted at baseline and at weeks 2, 4, 8, and 12.